DBH Polyclonal Antibody

Dopamine beta-hydroxylase encoded by DBH is an oxidoreductase belonging to the copper type II, ascorbate-dependent monooxygenase family. It is present in the synaptic vesicles of postganglionic sympathetic neurons and converts dopamine to norepinephrine. It exists in both soluble and membrane-bound forms, depending on the absence or presence, respectively, of a signal peptide.

The DBH Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of dopamine beta-hydroxylase (DBH) protein in various biological samples. This antibody is produced using state-of-the-art technology and has been rigorously validated to ensure optimal performance and reliability.

DBH is an essential enzyme involved in the conversion of dopamine to norepinephrine, playing a crucial role in the regulation of neurotransmitter levels. The DBH Polyclonal Antibody recognizes and binds to DBH with high affinity, enabling accurate measurement of DBH protein expression in tissues and cells.

This antibody exhibits exceptional specificity, exhibiting minimal cross-reactivity with other related proteins, ensuring reliable and accurate results. It is suitable for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The DBH Polyclonal Antibody is supplied as a liquid formulation, allowing for easy handling and convenient storage. It is provided in a ready-to-use format, eliminating the need for time-consuming preparation steps. The antibody is available in different sizes to accommodate various experimental needs.

With its superior sensitivity and specificity, the DBH Polyclonal Antibody is an indispensable tool for researchers and scientists studying the role of DBH in various physiological and pathological processes. Its reliable performance and ease of use make it an ideal choice for both basic research and clinical applications.

Order the DBH Polyclonal Antibody today and unlock new insights into the intricate mechanisms underlying neurotransmitter regulation.